BONK, INC. current report, 15 May 2024

Filing Overview

Registrant: Safety Shot, Inc., despite the request metadata identifying BONK, INC. The filing does not identify BONK, INC. as the registrant.

Form 8-K date: May 15, 2024. The report covers a Regulation FD disclosure and related exhibit filing; it does not present a financial reporting period.

Securities: Common stock, ticker SHOT, and warrants exercisable at $8.50 per share, ticker SHOTW, both listed on Nasdaq.

Financial Metrics and Capitalization

The filing text does not provide clear values for revenue, profit or loss, cash flow, margins, debt, liquidity, operating expenses, or other financial metrics.

Material Changes and Corporate Disclosure

On May 15, 2024, the company issued a press release under Item 7.01, Regulation FD Disclosure. The press release was furnished as Exhibit 99.1 and incorporated by reference, but its substantive contents are not included in the provided filing text.

No specific material change versus a prior comparable period is disclosed in the supplied text.

Outlook, Risks, and Unusual Items

The supplied filing text does not state guidance, forecasts, management commentary, contingencies, or risk updates. The principal limitation is that the referenced press release is not provided.

The company identified itself as an emerging growth company and indicated that it has not elected to forgo the extended transition period for complying with new or revised accounting standards.

Investor Verification Checklist

  • Verify the intended company, because the metadata names BONK, INC. while the filing identifies Safety Shot, Inc.
  • Obtain and review Exhibit 99.1 to determine the actual Regulation FD announcement.
  • Confirm whether the press release contains financial guidance, operational milestones, financing information, or material risks.
  • Review the company’s latest periodic filing for current financial condition, liquidity, debt, and operating results.
  • Confirm the terms and status of the SHOTW warrants, including the $8.50 exercise price.